ADM unveils new nutritional solutions platform for GLP-1 and AOM users

ADM unveils its supportive solutions platform for users of GLP-1 and other anti-obesity medications (AOMs). The solutions platform leverages in-depth scientific research and market analysis and utilizes ADM’s ingredient resources and comprehensive product development capabilities and supports the growing need for personalized nutrition for consumers using or discontinuing AOMs.

According to the company’s proprietary research, 83% of US consumers taking AOMs find food products to be appealing when they are specifically marketed as supportive of people on GLP-1 medications. The launch comes on the heels of experts and researchers calling for modified nutritional guidelines and holistic support for consumers using GLP-1 and AOMs.

“The use of GLP-1 treatments continues to rapidly increase, creating an incredibly dynamic market with a new segment of consumers with unique needs,” says Ian Pinner, SVP, president for nutrition and chief sales and marketing officer at ADM.

Complementary concepts

ADM has developed over 25 GLP-1 complementary food and supplement concepts, targeting specific needs of AOM users with clean, plant-based ingredients. 

These include prebiotics, probiotics, postbiotics, botanical extracts and sweetening solutions, along with resistant tapioca starch, digestive-support flour blends, keto-friendly flour replacers and natural flavors and colors.

According to its research, US adults on AOMs prioritize nutrition, taste and portion size more since starting GLP-1 treatments. They’re also more experimental with food, with 74% trying new foods and 83% cooking more at home. Additionally, the company notes that many respondents said they increased their intake of plant-based proteins (41%), fiber (49%) and probiotics or prebiotics (39%).

“Food, beverage and dietary supplement manufacturers can support consumers with tailored solutions that address their needs at every stage of their weight management journey,” Pinner underscores.

“Our tested and ready-to-market concepts tap into our unparalleled pantry and our full-formulation expertise to accelerate food and beverage manufacturers’ speed to market and help them differentiate with elevated format, flavor, texture and functionality.” 

Support through all stages

ADM’s supportive solutions platform narrows in on five needs, as spotlighted in the company’s research, during and after AOM usage. During the use of AOMs, ADM focuses on three key issues — maintaining muscle mass, minimizing gastrointestinal discomfort and ensuring hydration. As with other companies, the products speak to the opportunities the medications have opened within the expanding weight management market.

ADM unveils over 25 GLP-1 and AOM complementary products.As 20–40% of weight loss typically involves muscle loss, ADM employs plant-based proteins and wholesome ingredients to support lean muscle mass. Additionally, 40% of AOM users report gastrointestinal issues, which ADM addresses with its prebiotic dietary fibers and probiotics that are clinically proven to support digestive health. 

Moreover, 44% of users feel less hydrated, prompting ADM to enhance hydration through appealing beverage solutions using coconut water powder, sweetening options and flavor technologies.

“We are also delivering highly sought-after nutrient density in smaller servings and providing alternative solutions to support reducing persistent thoughts about food, commonly known as ‘food noise,’ if medication use is reduced,” Pinner explains.

When discontinuing or reducing the use of AOMs, ADM stresses that maintaining satiety and managing weight regain is critical. As “food noise” might return, the company offers dietary solutions like prebiotic fiber and resistant tapioca starch that enhance satiety. 

A growing space for innovation

ADM’s latest extensive offerings comes alongside other companies’ forays into the space, including Nestlé’s Vital Pursuit product line and Kourtney Kardashian’s Lemme supplement.

Furthermore, ADM provides products aimed at metabolic health, including biotics, carb-conscious ingredients, sweetening solutions and high-protein options to aid in weight management.

“Through our platform, we’re addressing the changing taste preferences that may come with engaging with GLP-1 medications, such as the altered perception of sweetness,” Pinner concludes.